Record Quarterly Billings and EPS
Q4 non-GAAP gross billings of $24.3B (+15% YoY; +13% constant currency) and non-GAAP diluted EPS of $3.83 (+24% YoY), both company records demonstrating strong top-line and earnings leverage.
Strong HIVE Growth
HIVE gross billings grew more than 50% YoY in Q4, with ODM/centimeters gross billings up 39% YoY; HIVE operating income also grew meaningfully and is becoming a larger portion of the mix.
Distribution Business Momentum (Excluding HIVE)
TD SYNNEX (ex-HIVE) gross billings increased 10% YoY in Q4, with gross profit and operating income each growing by double digits, indicating healthy core-distribution performance.
Solid Net Revenue, Gross Profit and Operating Income
Net revenue of $17.4B (+10% YoY); gross profit $1.2B (+15% YoY); non-GAAP operating income $497M (+18% YoY) and operating margin improved 5 basis points YoY to 2.04%.
Free Cash Flow and Shareholder Returns
Annual free cash flow of $1.4B (also $1.4B in the quarter), third consecutive year >$1B; returned $209M to shareholders in Q4 ($173M buybacks, $36M dividends) and $742M for the fiscal year; cumulative 3-year returns >$2.2B (~61% of FCF).
Regional and Product Strength
Broad-based geographic growth: stronger-than-expected Europe and robust Asia Pacific & Japan expansion driven by cloud, PC refresh, and AI development. Endpoint solutions gross billings +12% YoY (PCs in double digits for four consecutive quarters).
Strategic Execution and Market Recognition
Investments in omnichannel/digital platform and AI assistant (self-service 24/7) with reported operational time savings; awards include UK iCloud Marketplace of the Year (CRN) and Cisco Distributor of the Year (global, Americas, EMEA). Won a global security RFP.
Disciplined Cost and Balance Sheet Management
Non-GAAP SG&A $698M (3% of gross billings); cost-to-gross-profit ratio improved ~100 bps YoY to 58%. Net working capital down ~$300M YoY; gross cash days improved by 2 days; cash $2.4B, debt $4.6B, gross leverage 2.4x, net leverage 1.1x.
Forward Guidance and Capital Allocation
Q1 FY26 gross billings guidance $22.7B–$23.7B (~+12% at midpoint), net revenue guidance $15.1B–$15.9B (implied ~33% gross-to-net), Q1 dividend approved $0.48/share, $1.2B remaining buyback authorization.